Tvardi Therapeutics
TVRD· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock -76.6% in FY2025
Imran Alibhai, Ph.D. is the CEO of Tvardi Therapeutics and was paid $3.1M in FY2025 (Dec), up 263%.
Pay$100 in the stock at the end of FY23 → $16
Executives6
See all- 1Imran Alibhai, Ph.D.Chief Executive Officer and DirectorFY2025
- 2Christopher PosnerFormer (Cara) President and Chief Executive OfficerFY2025
- 3John Kauh, M.D.Chief Medical OfficerFY2025
- 4Dan Conn, J.D., M.B.A.Chief Financial OfficerFY2025
- 5Ryan MaynardFormer (Cara) Chief Financial OfficerFY2025
- 6Scott TerrillionFormer (Cara) General Counsel, Secretary and Chief Compliance OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allTvardi Therapeutics paid its 6 named executives $10.2M in total in FY2025 (Dec). CEO Imran Alibhai, Ph.D. was paid $3.1M of that.
| Name | |||
|---|---|---|---|
| Imran Alibhai, Ph.D.Chief Executive Officer and Director | Not disclosed | ||
| Christopher PosnerFormer (Cara) President and Chief Executive Officer | Not disclosed | ||
| John Kauh, M.D.Chief Medical Officer | Not disclosed | Not disclosed | |
| Dan Conn, J.D., M.B.A.Chief Financial Officer | Not disclosed | ||
| Ryan MaynardFormer (Cara) Chief Financial Officer | Not disclosed | ||
| Scott TerrillionFormer (Cara) General Counsel, Secretary and Chief Compliance Officer | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Tvardi Therapeutics. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board4
See all- Martin VogelbaumChair · 13 yr on the boardIndependentAudit, Compensation, Nominating and Corporate Governance—Paid as an executive
- Jeffrey L. Ives, Ph.D.Director · 9 yr on the boardIndependentAudit, Compensation, Nominating and Corporate Governance—Paid as an executive
- Susan Shiff, Ph.D.Director · 3 yr on the boardIndependentCompensation, Nominating and Corporate Governance—Paid as an executive
- Lisa von MoltkeDirector · 1 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive
The board of the latest proxy (FY2023).
Activity
Filings5
See all| Proxy statement | DEF 14A | Apr 23, 2026 | FY2025 |
| Annual report | 10-K | Mar 31, 2026 | FY2025 |
| Annual report | 10-K | Mar 11, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 22, 2024 | FY2023 |
| Annual report | 10-K | Mar 6, 2024 | FY2023 |
